brucecarletonBruce C. Carleton, CPNDS Chief Executive Officer

“My research focus is on the impact of drug therapy on human health and quality of life”, says Dr. Carleton. “My lifelong goal is to make medication use safer and more effective for all patients – particularly children”.

Dr. Carleton is researching better ways to evaluate the effectiveness of drugs, medication-use models designed to improve patient health, and practical surveillance systems to improve the safe use of medication. He has clinical interests in the use of medications in children, as well as the epidemiology, pharmacogenomics and clinical management of adverse drug events.

“The key element of my research is the communication of results to clinicians, patients, health care administrators, and government staff, who also hold responsibilities to improve patient care and our systems of healthcare delivery,” says Dr. Carleton.

Dr. Carleton is a senior clinician scientist at CFRI, a professor of Pediatrics at UBC, and director of the Pharmaceutical Outcomes Programme at BC Children’s Hospital and BC Women’s Hospital & Health Centre, agencies of the Provincial Health Services Authority.